Tereza Moore has worked in the field of mitochondrial biology for more than 10 years. As a clinical biochemical genetics fellow at Stanford University, she gained expertise in diagnosing and follow-up testing for individuals with mitochondrial disease. Following her training, she continued her research in the biochemical genetics lab at Stanford investigating new paths in diagnosis and therapy of mitochondrial-associated diseases, including Parkinson’s disease. Her scientific career has been focused on understanding the metabolic consequences of mitochondrial dysfunction, characterizing biomarkers for use in diagnosis and therapeutic monitoring and developing therapies that mitigate the negative consequences of mitochondrial dysfunction. Her contribution to science includes developing mass spectrometry assays to measure metabolic intermediates, identifying metabolic signatures in tissue samples and discovering a promising therapeutic target for treating disorders with mitochondrial dysfunction.